Durvalumab,Carboplatin,Paclitaxel,Cisplatin,Gemcitabine,Pemetrexed
Astrazeneca
[]
ras mutations are in some of the most common and aggressive tumors. but the mutations haven t been easily druggable. discuss the latest with drs. tim heffernan, john heymach, scott kopetz and ferdinandos skoulidis in #aacr23 booth 1501 today, 4/18, at 2 p.m. 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789